Today on DrugResearcher.com
 
The most pioneering drugs at cancer showcase

Let there be dark to see nature's cancer drugs

Wellcome boost for Alzheimer's research

GSK to strip down through outsourcing and offshoring

Cholesterol-releasing enzyme to reduce heart disease?

 
   
Related Industry News
 
Gardasil vs Cervarix - winner gets UK supply contract

Singapore's output down

GSK axe begins to fall

Pharmaceutical manufacturing: news in brief

 
 
Baxter Biopharma Solutions

Drug discovery

Breaking News on Drug Discovery
Daily  Friday 26 October 2007 Forward to a colleague

Product Brochure

Drop profiling for all aspects of drug developmentHigh precision optical profiling of liquid drops enhances drug discovery

Whether you are characterizing the uptake of active drug substances or controlling the quality of packaging materials, contact angle provides a quick, easy and sensitive measure of quality and cleanliness in research, QC and process control... Click Here

Access Full Stories



The most pioneering drugs at cancer showcase
As the AACR-NCI-EORTC cancer conference comes to an end today in San Francisco, DrugResearcher.com takes a look at some of the most innovative drugs on show... Read


Let there be dark to see nature's cancer drugs
Scientists are hoping to see the dark amongst the light as they scour nature for its next anticancer drug 'gift'... Read


Wellcome boost for Alzheimer's research
The UK's largest charity, the Wellcome Trust, has awarded £1.3m (€1.9m) to fund the world's largest ever genome-wide association study to identify the genetic origins of Alzheimer's disease... Read


GSK to strip down through outsourcing and offshoring
GlaxoSmithKline (GSK) is planning to strip itself down closer to the bare bones of the business through further outsourcing and offshoring, with hopes of making itself into a lean, mean, pharma machine... Read


Cholesterol-releasing enzyme to reduce heart disease?
US researchers have identified an enzyme that reduces the build up of heart-disease causing plaques by removing the cholesterol that causes them to form... Read


All News Headlines for:
October | September | August

Related Industry News



Gardasil vs Cervarix - winner gets UK supply contract
The race is one between cervical cancer vaccines Gardasil and Cervarix as they begin to battle it out to win a more than £100m a year supply contract with the UK Department of Health... Read


Singapore's output down
Figures released today reveal a slow-down in Singapore's pharmaceutical manufacturing output compared to this time last year... Read


GSK axe begins to fall
GlaxoSmithKline (GSK) has been swift in implementing its plant cuts, already announcing the first sites to be axed mere hours afters after revealing its restructuring plans... Read


Pharmaceutical manufacturing: news in brief
In-PharmaTechnologist.com brings you a selection of other headlines from the pharmaceutical manufacturing industry... Read

Weekly Comment

'We are not anti-Asia' says EU chemicals body

There have been more calls this month to tighten regulations on pharmaceutical ingredient suppliers in the wake of the recent safety concerns emanating from low-cost regions such as China and India.  However, despite having recently established a dedicated 'China Taskforce', a major EU chemicals consortium insists that it has nothing against the region or its manufacturers. Read



Previous Headlines



GSK cut down by Avandia scare
GlaxoSmithKline (GSK) has emerged as the latest pharma firm to announce closures and job cuts along with its third quarter results, yet another casualty of generic competition and product safety scares... Read


Illumina's revenue soars as Affymetrix sues again
Illumina's third quarter revenues soared 82 per cent while Affymetrix looked to bolster its slice of the genetics market by filing more patent infringement claims against the young pretender... Read


Sanofi slammed by FDA over failure to act on Ketek fraud
The US Food and Drug Administration (FDA) has slammed Sanofi-Aventis over its failure to act on known instances of fraud during clinical trials of its antibiotic Ketek (telithromycin) - accusations that the firm... Read


Personalised medicine leaves public cold
For some people, the promise of personalised medicine just means more worry and potential stigmatisation and they'd simply rather not know if they are genetically susceptible to a certain disease, such as cancer... Read


Drugs moving into the clinic: 32
The latest in a series of periodic roundups of drugs that have moved from preclinical research into clinical testing via the announcement of a Phase I trial or an application for a trial to industry regulators... Read

Technical / White Papers, Case studies, Web casts
Benefits of integrating human tissue research in drug discovery - Technical / White Paper

Manufacturing Variations in Polysorbate Batches - Technical / White Paper



Product Information - brochures, Web centers
DAICEL chiral chromatography products - Company Profile

Rapid HPLC method development with ChromSword®Auto software - Product Presentation

Separation of polar compounds - Application Notes



Product Innovation Alerts - Free of Charge
Indicate your research interests and receive alerts on relevant products and market innovations
Analysis and instrumentation
Assays and screening
Cell culture & Equipment
Chromatography
Compounds and consumables
Contract services (outsourcing)
Drug discovery
Genomics / Proteomics
Informatics & IT
Lab equipment & consumables
Liquid handling and automation
Liquid handling and sample preparation
Production technologies
Separation and purification




Free Newsletters for Pharmaceuticals
Access now !Choose from over 20 industry e-newsletters
Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here

Forward to a colleague

To continue to receive this newsletter in your inbox, please add
newsletter@DrugResearcher.com to your address book

Update preferences | Change your email address | Unsubscribe

Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback

© 2007 - Decision News Media S.A.S - All Rights Reserved
Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France
http://www.decisionnewsmedia.com